Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
20
ADAP Quote, Financials, Valuation and Earnings
Last price:
$0.60
Seasonality move
:
36.97%
Day range:
$0.59 - $0.61
52-week range:
$0.47 - $2.05
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.85x
P/B ratio:
1.93x
Volume:
3.1M
Avg. volume:
2.7M
1-year change:
37.05%
Market cap:
$154.8M
Revenue:
$60.3M
EPS (TTM):
-$0.18
Adaptimmune Therapeutics PLC SEC Filings
| Company | Filed | Form Type | Description | |
|---|---|---|---|---|
|
ADAP
Adaptimmune Therapeutics PLC
|
11/08/2023 | 10-Q | 10-Q filing on 11/08/2023 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
08/09/2023 | 10-Q | 10-Q filing on 08/09/2023 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
05/12/2023 | 10-Q | 10-Q filing on 05/12/2023 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
11/08/2022 | 10-Q | 10-Q filing on 11/08/2022 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
08/04/2022 | 10-Q | 10-Q filing on 08/04/2022 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
05/09/2022 | 10-Q | 10-Q filing on 05/09/2022 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
11/04/2021 | 10-Q | 10-Q filing on 11/04/2021 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
08/09/2021 | 10-Q | 10-Q filing on 08/09/2021 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
05/06/2021 | 10-Q | 10-Q filing on 05/06/2021 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
11/05/2020 | 10-Q | 10-Q filing on 11/05/2020 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
08/06/2020 | 10-Q | 10-Q filing on 08/06/2020 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
05/28/2020 | 10-Q | 10-Q filing on 05/28/2020 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
05/14/2020 | 10-Q | 10-Q filing on 05/14/2020 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
02/27/2020 | 10-K | 10-K filing on 02/27/2020 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
11/06/2019 | 10-Q | 10-Q filing on 11/06/2019 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
08/01/2019 | 10-Q | 10-Q filing on 08/01/2019 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
05/06/2019 | 10-Q | 10-Q filing on 05/06/2019 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
02/27/2019 | 10-K | 10-K filing on 02/27/2019 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
11/06/2018 | 10-Q | 10-Q filing on 11/06/2018 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
08/02/2018 | 10-Q | 10-Q filing on 08/02/2018 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
05/09/2018 | 10-Q | 10-Q filing on 05/09/2018 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
03/15/2018 | 10-K | 10-K filing on 03/15/2018 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
11/02/2017 | 10-Q | 10-Q filing on 11/02/2017 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
08/03/2017 | 10-Q | 10-Q filing on 08/03/2017 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
05/10/2017 | 10-Q | 10-Q filing on 05/10/2017 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
04/06/2017 | 10-Q | 10-Q filing on 04/06/2017 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
03/13/2017 | 10-K | 10-K filing on 03/13/2017 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
11/10/2016 | 10-Q | 10-Q filing on 11/10/2016 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
08/08/2016 | 10-Q | 10-Q filing on 08/08/2016 | View Form |
|
ADAP
Adaptimmune Therapeutics PLC
|
05/12/2016 | 10-Q | 10-Q filing on 05/12/2016 | View Form |
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
